Duloxetine Delayed-Release Capsules 30mg
Breckenridge Pharmaceutical is recalling 30mg Duloxetine capsules due to levels of N-nitroso-duloxetine impurity exceeding FDA limits.
Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking your medication without consulting a medical professional.
Why it was recalled
Breckenridge Pharmaceutical is recalling specific lots of Duloxetine Delayed-Release Capsules, 30mg, due to the presence of N-nitroso-duloxetine impurity levels exceeding the FDA-recommended interim limit. This recall involves 1000-count bottles.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Duloxetine Delayed-Release Capsules, USP
| Strength | NDC / UPC |
|---|---|
| 30 mg | NDC 51991-747-10 |
| 60 mg | NDC 51991-748-90 |
Official source
Other recent recalls from Breckenridge Pharmaceutical, Inc.
Editorial summary by Recall Canary · last updated 2026-06-09 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification